​2017,NO.3

发布时间:2017-02-08 15:13:00
分享到:
Based on the research of schisandrin C, Institute of Materia Medica has successfully developed bifendate and bicyclol, and accomplished their industrialization and internationalization by IUR collaborative innovation. Bifendate and bicyclol provided the new treatment schemes of liver protection and anti-inflammation in China. The research achievements reached the international advanced level.

 

Bifendate tablets and pills had been approved on the market in the early 1980s. Bifendate pills, which had a higher bioavailability than bifendate tablets, has won the first prize in the Ministry of Health of PRC Science and Technology Award, the third prize in the National Technical Invention Award and gold medal in the Eureka world Invention Exposition.

 

Bicyclol tablets launched in 2001 were China`s first type of synthetic drug on the market with independent intellectual property rights internationally. They have won the first prize of Beijing Science and Technology Award and the second prize of the National Science and Technological Progress Award.

  • 公众号
    中国实验动物学会
    订阅号
    中国实验动物学会
    实验动物与健康生活
    党员e家
    实验动物学会
  • 返回
    顶部